Literature DB >> 7895009

Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis.

B Runmarker1, O Andersen.   

Abstract

The effects of pregnancy were studied in a multiple sclerosis incidence cohort. In order to eliminate interaction bias between the disease and pregnancy, analysis of the risk of relapse during pregnancy and the puerperium was limited to the onset bout, using fecundity figures for Sweden. The risk of onset bout was significantly reduced during pregnancy while the risk of onset bout in the post-partum period did not differ significantly from the risk during non-pregnancy periods. We also found a decreased risk of multiple sclerosis onset in parous compared with nulliparous women. The association between nulliparity and multiple sclerosis tended to increase with age. Furthermore, the effect of pregnancy on the long-term prognosis in established multiple sclerosis was analysed by comparing the risk of change from a relapsing-remitting to a chronic progressive course and the risk of reaching level 6 of the Disability Status Scale in women with pregnancy after multiple sclerosis onset with that in non-pregnant control patients, matched for neurological deficit, disease duration and age. There was a significantly decreased risk of a progressive course in women who were pregnant after multiple sclerosis onset.

Entities:  

Mesh:

Year:  1995        PMID: 7895009     DOI: 10.1093/brain/118.1.253

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  60 in total

Review 1.  The genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

2.  Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice.

Authors:  Lola Weiss; Steve Bernstein; Richard Jones; Ravi Amunugama; David Krizman; Lellean Jebailey; Osnat Almogi-Hazan; Osnat Hazan; Zhanna Yekhtin; Janna Yachtin; Reut Shiner; Israel Reibstein; Elizabeth Triche; Shimon Slavin; Reuven Or; Eytan R Barnea
Journal:  Endocrine       Date:  2011-03-22       Impact factor: 3.633

Review 3.  Intravenous immunoglobulin therapy in neurological diseases during pregnancy.

Authors:  Isabel Ringel; Uwe K Zettl
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 4.  Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease.

Authors:  Nicholas P Deems; Benedetta Leuner
Journal:  Front Neuroendocrinol       Date:  2020-01-24       Impact factor: 8.606

Review 5.  Estrogen and testosterone therapies in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

Review 6.  Clinical prognostic factors in multiple sclerosis: a natural history review.

Authors:  Alexandra Degenhardt; Sreeram V Ramagopalan; Antonio Scalfari; George C Ebers
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

Review 7.  The neurology of pregnancy.

Authors:  G V Sawle; M M Ramsay
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

Review 8.  Genetic epidemiology of multiple sclerosis.

Authors:  A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

9.  Breastfeeding, ovulatory years, and risk of multiple sclerosis.

Authors:  Annette Langer-Gould; Jessica B Smith; Kerstin Hellwig; Edlin Gonzales; Samantha Haraszti; Corinna Koebnick; Anny Xiang
Journal:  Neurology       Date:  2017-07-12       Impact factor: 9.910

10.  Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).

Authors:  Stefan M Gold; Manda V Sasidhar; Laurie B Morales; Sienmi Du; Nancy L Sicotte; Seema K Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2009-08-10       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.